Nicholas McGrane is CFO at Evolent Health, Inc. (EVH). They have made 4 open-market trades across 1 company since 2016, most recently 2019-03-01.
CIK 0001643086
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EVH | 84,088 | $404K |
Shares reported on the most recent Form 4, priced at the 2019-03-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVH | SELL · 10b5-1 | 2017-07-10 | 2017-07-12 | $25.42 | $42K | +1.1% | -29.5% | -36.4% |
| EVH | SELL · 10b5-1 | 2017-06-12 | 2017-06-14 | $24.58 | $41K | +2.7% | +4.7% | -29.6% |
| EVH | SELL | 2017-06-06 | 2017-06-08 | $26.95 | $283K | -3.1% | -7.1% | -34.7% |
| EVH | SELL | 2017-05-19 | 2017-05-23 | $24.30 | $2.3M | +11.6% | +10.9% | -26.1% |
| EVH | SELL · 10b5-1 | 2017-05-10 | 2017-05-12 | $24.28 | $40K | -5.7% | -5.1% | -30.4% |
| EVH | SELL · 10b5-1 | 2017-04-19 | 2017-04-21 | $22.52 | $38K | +4.7% | +3.5% | +16.9% |
| EVH | SELL | 2017-03-24 | 2017-03-27 | $22.50 | $271K | +7.3% | +7.5% | +26.9% |
| EVH | SELL | 2016-09-14 | 2016-09-15 | $21.54 | $914K | -0.7% | +0.3% | -27.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.